In the management of disseminated intravascular coagulation (DIC), which approach is central?

Get ready for the CAMLPR Hematology Test. Use our quizzes, flashcards, and detailed explanations to enhance your understanding. Prepare confidently for your exam!

Multiple Choice

In the management of disseminated intravascular coagulation (DIC), which approach is central?

In DIC, the priority is to stop the insult driving the process and to support the patient’s hemostasis by replacing what's been consumed. Treating the underlying cause is essential, and providing blood product support helps restore clotting ability and oxygen delivery. Fresh frozen plasma supplies the coagulation factors that become depleted, helping to correct the coagulopathy, while packed red blood cells replace blood loss and improve circulation. This combination addresses both the trigger and the bleeding risk at once, which is why it’s the central approach. Starting high-dose heparin is generally not used when there is active bleeding, and it’s reserved only for specific scenarios with dominant thrombosis and minimal hemorrhage. Aspirin would worsen bleeding by inhibiting platelet function. Giving platelets alone does not correct the broader coagulation factor deficiencies and consumption seen in DIC, though platelets may be used judiciously if there is severe thrombocytopenia with bleeding.

In DIC, the priority is to stop the insult driving the process and to support the patient’s hemostasis by replacing what's been consumed. Treating the underlying cause is essential, and providing blood product support helps restore clotting ability and oxygen delivery. Fresh frozen plasma supplies the coagulation factors that become depleted, helping to correct the coagulopathy, while packed red blood cells replace blood loss and improve circulation. This combination addresses both the trigger and the bleeding risk at once, which is why it’s the central approach.

Starting high-dose heparin is generally not used when there is active bleeding, and it’s reserved only for specific scenarios with dominant thrombosis and minimal hemorrhage. Aspirin would worsen bleeding by inhibiting platelet function. Giving platelets alone does not correct the broader coagulation factor deficiencies and consumption seen in DIC, though platelets may be used judiciously if there is severe thrombocytopenia with bleeding.

More practice questions